By Professor Michael Proinsias Farrell

Journal articles

Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M, 2017, 'Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England', Addiction, 112, pp. 1408 - 1418, http://dx.doi.org/10.1111/add.13779

Nielsen S; Sabioni P; Trigo JM; Ware MA; Betz-Stablein BD; Murnion B; Lintzeris N; Khor KE; Farrell M; Smith A; Le Foll B, 2017, 'Opioid-sparing effect of cannabinoids: A systematic review and meta-analysis', Neuropsychopharmacology, 42, pp. 1752 - 1765, http://dx.doi.org/10.1038/npp.2017.51

Stockings E; Farrell M, 2017, 'Drinking-reduction goals offer potential to widen the options for measuring and treating alcohol dependence', The Lancet Psychiatry, 4, pp. 430 - 431, http://dx.doi.org/10.1016/S2215-0366(17)30187-6

Saunders JB; Degenhardt L; Farrell M, 2017, 'Excessive gambling and gaming: addictive disorders?', The Lancet Psychiatry, 4, pp. 433 - 435, http://dx.doi.org/10.1016/S2215-0366(17)30210-9

Lappin JM; Sara GE; Farrell M, 2017, 'Methamphetamine-related psychosis: an opportunity for assertive intervention and prevention', Addiction, 112, pp. 927 - 928, http://dx.doi.org/10.1111/add.13663

Conroy M; Gallagher DJ; Farrell MP, 2017, 'Prevalence of BRCA1/2 mutations among an Irish cohort unrestricted by testing eligibility thresholds', JOURNAL OF CLINICAL ONCOLOGY, 35, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e13013

Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD, 2017, 'Crystalline methamphetamine use and methamphetamine-related harms in Australia', Drug and Alcohol Review, 36, pp. 160 - 170, http://dx.doi.org/10.1111/dar.12426

Stillwell G; Jones H; Shaw J; Farrell M; Marsden J, 2017, 'An evaluation of opioid substitution treatment in prison on risk of mortality in period immediately after prison: Does leaving prison on OST reduce the risk of death?', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E197 - E197, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.538

Campbell G; Bruno R; Cohen M; Hall W; Nielsen S; Lintzeris N; Larance B; Mattick RP; Farrell M; Degenhardt L, 2017, 'Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic non-cancer pain: Different measures, same patients?', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E33 - E33, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.103

Ritter A; Hoang VP; Cao VL; Shanahan M; Shukla N; Perez P; Farrell M, 2017, 'Modelling heroin careers over 40 years: Social costs', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E177 - E177, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.486

Farrell MP; Hearty KP; Gallagher DJ, 2017, 'Prevalence of pathogenic mismatch repair mutations in an Irish cohort after clinical and molecular pre-selection.', JOURNAL OF CLINICAL ONCOLOGY, 35, http://dx.doi.org/10.1200/JCO.2017.35.4_suppl.574

Darke S; Larney S; Farrell M, 2017, 'Yes, people can die from opiate withdrawal', Addiction, 112, pp. 199 - 200, http://dx.doi.org/10.1111/add.13512

Saunders JB; Hao W; Long J; King DL; Mann K; Fauth-Bühler M; Rumpf HJ; Bowden-Jones H; Rahimi-Movaghar A; Chung T; Chan E; Bahar N; Achab S; Lee HK; Potenza M; Petry N; Spritzer D; Ambekar A; Derevensky J; Griffiths MD; Pontes HM; Kuss D; Higuchi S; Mihara S; Assangangkornchai S; Sharma M; El Kashef A; Ip P; Farrell M; Scafato E; Carragher N; Poznyak V, 2017, 'Gaming disorder: Its delineation as an important condition for diagnosis, management, and prevention', Journal of Behavioral Addictions, 6, pp. 271 - 279, http://dx.doi.org/10.1556/2006.6.2017.039

Courtney RJ; Clare P; Boland V; Martire KA; Bonevski B; Hall W; Siahpush M; Borland R; Doran CM; West R; Farrell M; Mattick RP, 2017, 'Predictors of retention in a randomised trial of smoking cessation in low-socioeconomic status Australian smokers', Addictive Behaviors, 64, pp. 13 - 20, http://dx.doi.org/10.1016/j.addbeh.2016.07.019

Van Buskirk J; Griffiths P; Farrell M; Degenhardt L, 2017, 'Trends in new psychoactive substances from surface and “dark” net monitoring', The Lancet Psychiatry, 4, pp. 16 - 18, http://dx.doi.org/10.1016/S2215-0366(16)30405-9

Nielsen S; Menon N; Larney S; Farrell M; Degenhardt L, 2016, 'Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal', Addiction, 111, pp. 2177 - 2186, http://dx.doi.org/10.1111/add.13517

Lappin JM; Roxburgh A; Kaye S; Chalmers J; Sara G; Dobbins T; Burns L; Farrell M, 2016, 'Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population', International Journal of Drug Policy, 38, pp. 16 - 20, http://dx.doi.org/10.1016/j.drugpo.2016.10.018

Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalf C; Shaw J; Hickman M, 2016, 'Does exposure to opioid substitution treatment at prison release reduce the risk of death? A prospective, observational study in England', LANCET, 388, pp. 11 - 11, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398515600012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Casey J; Flood K; Ennis S; Doyle E; Farrell M; Lynch SA, 2016, 'Intra-familial variability associated with recessive RYR1 mutation diagnosed prenatally by exome sequencing', PRENATAL DIAGNOSIS, 36, pp. 1020 - 1026, http://dx.doi.org/10.1002/pd.4925

Darke S; Farrell M, 2016, 'Commentary on Singh et al. (2016): Still searching for the answer', Addiction (Abingdon, England), 111, pp. 1347, http://dx.doi.org/10.1111/add.13369

Gethin A; Trimingham T; Chang T; Farrell M; Ross J, 2016, 'Coping with problematic drug use in the family: An evaluation of the Stepping Stones program', Drug and alcohol review, 35, pp. 470 - 476, http://dx.doi.org/10.1111/dar.12327

Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L, 2016, 'Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: Do different measures identify the same patients?', Pain, 157, pp. 1489 - 1498, http://dx.doi.org/10.1097/j.pain.0000000000000548

Bonevski B; Guillaumier A; Shakeshaft A; Farrell M; Tzelepis F; Walsberger S; D'Este C; Paul C; Dunlop A; Searles A; Kelly P; Fry R; Stirling R; Fowlie C; Skelton E, 2016, 'An organisational change intervention for increasing the delivery of smoking cessation support in addiction treatment centres: Study protocol for a randomized controlled trial', Trials, 17, http://dx.doi.org/10.1186/s13063-016-1401-6

Farrell MP; Truman GJ; Shea R; Hughes DJ; Gallagher DJ, 2016, 'Frequency of variants of uncertain significance in BRCA1 and BRCA2 in an Irish cohort.', JOURNAL OF CLINICAL ONCOLOGY, 34, http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.e13006

Gowing L; Farrell M; Ali R; White JM, 2016, 'Alpha2-adrenergic agonists for the management of opioid withdrawal', Cochrane Database of Systematic Reviews, 2016, http://dx.doi.org/10.1002/14651858.CD002024.pub5

Darke S; Farrell M, 2016, 'Response to commentaries on 'Which medications are suitable for agonist drug maintenance'', Addiction, 111, pp. 781 - 782, http://dx.doi.org/10.1111/add.13359

Darke S; Farrell M, 2016, 'Which medications are suitable for agonist drug maintenance?', Addiction, 111, pp. 767 - 774, http://dx.doi.org/10.1111/add.13158

Hoang VP; Shanahan M; Shukla N; Perez P; Farrell M; Ritter A, 2016, 'A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems', BMC Health Services Research, 16, pp. 127, http://dx.doi.org/10.1186/s12913-016-1368-8

Campbell G; Bruno R; Darke S; Shand F; Hall W; Farrell M; Degenhardt L, 2016, 'Prevalence and correlates of suicidal thoughts and suicide attempts in people prescribed pharmaceutical opioids for chronic pain', Clinical Journal of Pain, 32, pp. 292 - 301, http://dx.doi.org/10.1097/ajp.0000000000000283

Larney S; Farrell M, 2016, 'Commentary on Binswanger et al. (2016): Multiple opportunities exist to improve the health and wellbeing of people released from prisons', Addiction, 111, pp. 511 - 512, http://dx.doi.org/10.1111/add.13245

Larney S; Degenhardt L; Farrell M, 2016, 'Response to Bird et al.: The importance of post-release engagement in treatment in estimating impacts on post-release deaths', Addiction, 111, pp. 560 - 561, http://dx.doi.org/10.1111/add.13208

Farrell M, 2016, 'Swift and certain approaches to reduce alcohol reoffending', The Lancet Psychiatry, 3, pp. 189 - 190, http://dx.doi.org/10.1016/S2215-0366(15)00519-2

O'Kane G; McGarrigle SA; Rehill N; Farrell MP; O'Sullivan J; Muldoon C; Mac Mathuna PM; Carney DN; Gallagher DJ, 2016, 'Levels of oxidative stress and telomeres in Lynch syndrome-associated malignancies.', JOURNAL OF CLINICAL ONCOLOGY, 34, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.582

Wilson AJ; Bonevski B; Dunlop A; Shakeshaft A; Tzelepis F; Walsberger S; Farrell M; Kelly PJ; Guillaumier A, 2016, ''The lesser of two evils': A qualitative study of staff and client experiences and beliefs about addressing tobacco in addiction treatment settings', Drug and Alcohol Review, 35, pp. 92 - 101, http://dx.doi.org/10.1111/dar.12322

Ritter A; Schukla N; Shanahan M; Hoang P; Cao L; Perez P; Farrell M, 2016, 'Building a Microsimulation Model of Heroin Use Careers in Australia', The International Journal of Microsimulation, 9, pp. 140 - 176, http://dx.doi.org/10.34196/ijm.00146

Casner A; Liberatore S; Masse L; Martinez D; Haan SW; Kane J; Moore AS; Seugling R; Farrell M; Giraldez E; Nikroo A; Smalyuk VA; Remington BA, 2016, 'Experimental evidence of a bubble-merger regime for the Rayleigh-Taylor Instability at the ablation front', Journal of Physics: Conference Series, 717, pp. 012010 - 012010, http://dx.doi.org/10.1088/1742-6596/717/1/012010

Darke S; Farrell M, 2016, 'The twenty-first century opioid epidemic: What is happening and what can be done?', The Addictions Newsletter, Spring, pp. 18 - 20, http://www.apa.org/divisions/div50/Newsletters/tan-spring-2016.pdf

Mayet S; Farrell M; Mani SG, 2015, 'Opioid agonist maintenance for opioid dependent patients in prison', Cochrane Database of Systematic Reviews, 2015, http://dx.doi.org/10.1002/14651858.CD008221.pub2

Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber PS; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2015, 'LONGER TERM OUTCOMES FOR PHARMACEUTICAL OPIOID DEPENDENCE: 12 MONTH FINDINGS FROM AN IN-TREATMENT COHORT', DRUG AND ALCOHOL REVIEW, 34, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hoban B; Larance B; Gisev N; Nielsen S; Cohen M; Bruno R; Shand F; Lintzeris N; Hall W; Farrell M; Degenhardt L, 2015, 'The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids', International Journal of Clinical Practice, 69, pp. 1366 - 1376, http://dx.doi.org/10.1111/ijcp.12716

Larney S; Degenhardt L; Mattick RP; Farrell M, 2015, 'Variation in mortality risk of people released from prison', The Lancet Psychiatry, 2, pp. 681, http://dx.doi.org/10.1016/S2215-0366(15)00235-7

Farrell M; Marsden J; Strang J, 2015, 'Griffith Edwards, the Addiction Research Unit and research on the criminal justice system', Addiction, 110, pp. 54 - 58, http://dx.doi.org/10.1111/add.12910

Farrell M; Hall W, 2015, 'Heroin-assisted treatment: Has a controversial treatment come of age?', British Journal of Psychiatry, 207, pp. 3 - 4, http://dx.doi.org/10.1192/bjp.bp.114.160986

Smith K; Mattick RP; Bruno R; Nielsen S; Cohen M; Campbell G; Larance B; Farrell M; Degenhardt L, 2015, 'Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain', Journal of Affective Disorders, 184, pp. 72 - 80, http://dx.doi.org/10.1016/j.jad.2015.05.049

Degenhardt L; Bruno R; Ali R; Lintzeris N; Farrell M; Larance B, 2015, 'The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study', Drug and Alcohol Dependence, 151, pp. 56 - 67, http://dx.doi.org/10.1016/j.drugalcdep.2015.02.038

Davoli M; Amato L; Clark N; Farrell M; Hickman M; Hill S; Magrini N; Poznyak V; Schünemann HJ, 2015, 'The role of Cochrane reviews in informing international guidelines: A case study of using the grading of recommendations, assessment, development and evaluation system to develop World Health Organization guidelines for the psychosocially assisted pharmacological treatment of opioid dependence', Addiction, 110, pp. 891 - 898, http://dx.doi.org/10.1111/add.12788

McGarrigle SA; O'Kane G; Hooper S; Rehill N; Farrell MP; O'Sullivan J; Muldoon C; Mac Mathuna PM; Carney DN; Gallagher DJ, 2015, 'Lack of association of telomerase expression levels with telomere length variation in Lynch syndrome patients.', JOURNAL OF CLINICAL ONCOLOGY, 33, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e12527

Farrell MP; Clabby C; Shea RO; Green AJ; Gallagher DJ, 2015, 'MLH1 hypermethylation assay should be considered when evaluating mismatch repair deficient tumours.', JOURNAL OF CLINICAL ONCOLOGY, 33, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e12524

O Shea R; Farrell MP; Clarke R; Eileen B; Gallagher DJ, 2015, 'Next-generation sequencing as an informing phenotype: A TP53 example.', Journal of Clinical Oncology, 33, pp. 1554 - 1554, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.1554

Ntlholang O; Farrell M; Noone I; Charidimou A; Crowe M, 2015, 'Fatal intracerebral haemorrhage following intravenous thrombolysis for acute ischaemic stroke: A hidden role for cerebral amyloid angiopathy?', JOURNAL OF THE NEUROLOGICAL SCIENCES, 352, pp. 122 - 124, http://dx.doi.org/10.1016/j.jns.2015.03.030

Back to profile page